Skip to content

Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report

Felix Müller, Thomas Sauer, Corina Hänny, Markus Mühlhauser, Undine E. Lang

Psychiatry Research January 29, 2025 DOI: 10.1016/j.psychres.2025.116381 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case study Case report Peer reviewed
Sample size 1
Population 60-year-old man with recurrent depression and history of delusions
Intervention psilocybin-assisted therapy
Topics Psilocybin Psychedelic-assisted therapy
Keywords Hallucinogen Telepathy Psychotherapist Alternative medicine
Citations 11
Key findings Psilocybin-triggered delusions and emotional dysregulation may have contributed to the death of a patient with recurrent depression and history of delusions.

Abstract

• A 60-year-old man with recurrent depression and history of delusions died after psilocybin-assisted therapy. • Psilocybin-triggered delusions and emotional dysregulation may have contributed. • Weak therapeutic alliance hindered assessment of patient's internal state. • Delusional symptoms may contraindicate psychedelic interventions. • This case emphasizes the need for thorough assessment and close follow-up in complex cases.

Comparable studies

Other case reports and case series on psilocybin and psychedelic-assisted therapy, most cited first.

Study Year Design Participants
Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report 2025 Case study
Refractory CRPS pain treated with psilocybin: A case report A patient with refractory complex regional pain syndrome 2024 Case study n = 1
Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin—A retrospective case study A woman in her early forties with early complex trauma and treatment-resistant depression 2023 Case report n = 1
Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use A 36-year-old transwoman who was a daily methamphetamine user 2024 Case study n = 1
Long‐COVID symptoms improved after MDMA and psilocybin therapy: A case report 41-year-old fully vaccinated female with Long-COVID syndrome 2024 Case report n = 1

Explore topics

By condition and practice